|
Demographic characteristics
|
|
Age, years
|
42.2 (10.3)
|
21–63
|
|
Education, years
|
11.4 (2.3)
|
6–18
|
|
Female
|
27% (26)
| |
|
HIV +
|
6% (6)
| |
|
Hepatitis C diagnosisa
|
14% (14)
| |
|
Race/ethnicity
|
|
Non-Hispanic White
|
22% (21)
| |
|
Non-Hispanic Black/African-American
|
24% (23)
| |
|
Latinx
|
52% (50)
| |
|
Other
|
2% (3)
| |
|
Opioid use characteristics
|
|
SR heroin in last 30 days
|
87% (79)
| |
|
SR other opiates in last 30 days
|
33% (30)
| |
|
UT opiates
|
98% (92)
| |
|
Lifetime opioid use disorder
|
100% (97)
| |
|
Cannabis use characteristics
|
|
SR cannabis in last 30 days
|
44% (40)
| |
|
UT cannabis
|
25% (24)
| |
|
Lifetime cannabis use disorder
|
44% (42)
| |
|
Stimulant use characteristics
|
|
SR cocaine in last 30 days
|
40% (36)
| |
|
UT cocaine
|
28% (27)
| |
|
Lifetime cocaine use disorder
|
59% (57)
| |
|
SR amphetamines in last 30 days
|
2% (2)
| |
|
UT amphetamines
|
1% (1)
| |
|
Sedative use characteristics
|
|
SR alcohol in last 30 days
|
41% (37)
| |
|
SR alcohol to intoxication in last 30 days
|
24% (22)
| |
|
Lifetime alcohol use disorder
|
54% (52)
| |
|
SR sedatives in last 30 days
|
23% (21)
| |
|
UT benzodiazepines
|
11% (11)
| |
|
Lifetime sedative use disorder
|
28% (27)
| |
|
Psychological characteristics
|
|
BDI-II Total Score
|
15.4 (10.6)
|
0–45
|
|
Minimal total score ≤ 13
|
50% (45)
| |
|
Mild total score 14 and 19
|
17% (15)
| |
|
Moderate total score 20 and 28
|
23% (22)
| |
|
Severe total score 29 and 63
|
10% (9)
| |
|
CIDI lifetime major depressive disorder
|
37% (35)
| |
